Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Kwiatkowski
Equivalent Benefit of mTORC1 Blockade and Combined PI3K-mTOR Blockade in a Mouse Model of Tuberous Sclerosis
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Heterozygosity for the Tuberous Sclerosis Complex (TSC) Gene Products Results in Increased Astrocyte Numbers and Decreased P27-Kip1 Expression in TSC2+/− Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
Equivalent Benefit of Rapamycin and a Potent mTOR ATP-Competitive Inhibitor, MLN0128 (INK128), in a Mouse Model of Tuberous Sclerosis
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
IL-1 Receptor Blockade Skews Inflammation Towards Th2 in a Mouse Model of Systemic Sclerosis
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Survival Benefit and Phenotypic Improvement by Hamartin Gene Therapy in a Tuberous Sclerosis Mouse Brain Model
Neurobiology of Disease
Neurology
Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex
PLoS ONE
Multidisciplinary
Rapamycin Prevents Epilepsy in a Mouse Model of Tuberous Sclerosis Complex
Annals of Neurology
Neurology
Estrogen Receptor Β Ligand Therapy Activates PI3K/Akt/mTOR Signaling in Oligodendrocytes and Promotes Remyelination in a Mouse Model of Multiple Sclerosis
Neurobiology of Disease
Neurology
Dissociation of the Pharmacological Effects of THC by mTOR Blockade
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease
PLoS ONE
Multidisciplinary
